August 19, 2017 8:32 AM ET


Company Overview of Madrigal Pharmaceuticals, Inc.

Executive Profile

Marc R. Schneebaum

Chief Financial Officer and Senior Vice President, Madrigal Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2016


Mr. Marc R. Schneebaum has been the Chief Financial Officer and Senior Vice President at Madrigal Pharmaceuticals, Inc. since July 22, 2016. Mr. Schneebaum served as Chief Financial Officer and Senior Vice President of Synta Pharmaceuticals Corp., since December 8, 2014 and served its Treasurer. Mr. Schneebaum has over twenty years of demonstrated success in broad corporate finance, business development, technology development, sales & marketing and general management ...

Corporate Headquarters

200 Barr Harbor Drive
West Conshohocken, Pennsylvania 19428

United States

Phone: 484-380-9263
Fax: --

Board Members Memberships



University of Maryland

Other Affiliations

Annual Compensation

Total Annual Compensation$511,487

Stocks Options

Restricted Stock Awards$393,753
All Other Compensation$51,247
Exercisable Options$28,808
Exercisable Options Value$133,530
Unexercisable Options$79,996
Unexercisable Options Value$400,580
Total Value of Options$534,110
Total Number of Options$108,804

Total Compensation

Total Annual Cash Compensation$562,734
Total Short Term Compensation$511,487
Other Long Term Compensation$445,000
Total Calculated Compensation$1,685,622

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Madrigal Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at